MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AxoGen Retained Earnings 2011-2026 | AXGN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -307 M | -291 M | -281 M | -260 M | -231 M | -204 M | -180 M | -151 M | -128 M | -118 M | -103 M | -90.1 M | -72.4 M | -57.8 M | -48.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -48.4 M | -307 M | -168 M |
Quarterly Retained Earnings AxoGen
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -295 M | -295 M | -291 M | -292 M | -290 M | -288 M | -281 M | -277 M | -273 M | -267 M | -260 M | -254 M | - | -242 M | -231 M | -225 M | -218 M | -210 M | -204 M | -204 M | -204 M | -204 M | -180 M | -180 M | -180 M | -180 M | -151 M | -151 M | -151 M | -151 M | -128 M | -128 M | -128 M | -128 M | -118 M | -118 M | -118 M | -118 M | -103 M | -103 M | -103 M | -103 M | -90.1 M | -90.1 M | -90.1 M | -90.1 M | -72.4 M | -72.4 M | -72.4 M | -72.4 M | -57.8 M | -57.8 M | -57.8 M | -57.8 M | -48.4 M | -48.4 M | -48.4 M | -48.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -48.4 M | -295 M | -160 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 11.75 | -3.29 % | $ 1.76 B |  USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 8.98 | -1.32 % | $ 322 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.41 | 0.38 % | $ 121 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.35 | - | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 100.97 | 1.78 % | $ 1.28 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 62.4 | -1.33 % | $ 3.4 B |  Britain |
 |
LENSAR
LNSR
|
-143 M | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 86.58 | -0.68 % | $ 111 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
InspireMD
NSPR
|
-302 M | $ 1.79 | 3.47 % | $ 115 M | Israel |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Profound Medical Corp.
PROF
|
-130 M | $ 5.15 | -4.63 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Penumbra
PEN
|
238 M | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Myomo
MYO
|
-119 M | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.4 | -1.64 % | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
Quanterix Corporation
QTRX
|
-577 M | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
-1.17 B | $ 3.53 | -2.35 % | $ 53.7 K | USA |